证券代码：300203 证券简称：聚光科技 公告编号：2025-019 聚光科技（杭州）股份有限公司 第五届监事会第一次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 聚光科技(杭州)股份有限公司(下称"公司") 监事会于2025年5月8日以电 子邮件、书面传真和专人送达等方式发出召开公司第五届监事会第一次会议通 知。本次会议于2025年5月14日以现场结合通讯表决的方式召开。本次会议应参 加表决3人, 实际参加表决3人（其中韦俊峥先生以通讯表决方式参加），现场会 议由监事会成员赵玲女士主持出席，本次会议的召开符合《中华人民共和国公司 法》和公司章程的有关规定，会议决议合法、有效。 二〇二五年五月十四日 经与会监事审议并表决通过了以下议案： （一）审议通过了《关于选举公司第五届监事会主席的议案》 公司监事会选举赵玲女士为第五届监事会主席，任期三年，自本次会议通过 之日起至第五届监事会届满之日止。 表决结果: 同意: 3 票; 反对: 0 票; 弃权: 0 票 具体内容及简历详见中国证监会指定的创业板信息披露网站上披露的《关于 选 ...

证券代码：300203 证券简称：聚光科技 公告编号：2025-017 聚光科技（杭州）股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会无增加、变更、否决提案的情况； 2.本次股东大会以现场与网络投票相结合的方式召开。 一、会议召开和出席情况 聚光科技(杭州)股份有限公司(以下简称"公司") 2024年年度股东大会于 2025年4月22日以公告方式发出会议通知，于2025年5月14日在公司会议室召开。 本次会议采取现场投票与网络投票相结合的方式召开。本次会议通过深圳证券交 易所交易系统进行网络投票的时间为：2025年5月14日上午9:15-9:25，9： 30-11:30，下午13：00—15：00。本次会议通过深圳证券交易所互联网投票系统 投票的时间为：2025年5月14日9：15-15：00期间的任意时间。本次股东大会由 公司董事会召集，董事长顾海涛先生主持，公司部分董事、监事和高级管理人员 及公司聘请的见证律师等相关人士出席了本次会议。会议的召集、召开与表决程 序符合法律、行政法规、部门 ...

证券代码：300203 证券简称：聚光科技 公告编号：2025-018 聚光科技（杭州）股份有限公司 第五届董事会第一次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 聚光科技(杭州)股份有限公司(下称"公司")董事会于2025年5月8日以电子 邮件、书面传真和专人送达等方式发出召开公司第五届董事会第一次会议通知。 会议于2025年5月14日以现场表决与通讯表决相结合的方式召开, 应参加表决5 人, 实际参加表决5人（其中陈伟华女士以通讯表决方式参加），现场会议由董 事长顾海涛先生主持。本次会议的召开符合《中华人民共和国公司法》和公司章 程的有关规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事认真讨论，审议并表决通过了以下决议： （一）审议通过了《关于选举公司第五届董事会董事长的议案》 公司董事会选举顾海涛先生为第五届董事会董事长，任期三年，自本次会议 通过之日起至第五届董事会届满之日止。 本议案以5票同意，0票弃权，0票反对获得通过。 （二）审议通过了《关于选举公司第五届董事会各专门委员会委员的议案》 为强化公司 ...

证券代码：300203 证券简称：聚光科技 公告编号：2025-020 聚光科技（杭州）股份有限公司 关于选举公司董事长、董事会各专门委员会委员、监事会主席 及聘任高级管理人员和证券事务代表的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 聚光科技（杭州）股份有限公司（以下简称"公司"）于 2025 年 5 月 14 日召开了第五届董事会第一次会议、第五届监事会第一次会议，会议分别审议通 过了《关于选举公司第五届董事会董事长的议案》、《关于选举公司第五届董事 会各专门委员会委员的议案》、《关于聘任公司总经理的议案》、《关于聘任公 司其他高级管理人员的议案》、《关于聘任公司证券事务代表的议案》、《关于 选举公司第五届监事会主席的议案》等议案，现将有关情况公告如下： 一、选举公司第五届董事会董事长 公司董事会选举顾海涛先生为第五届董事会董事长，任期三年，自本次会议 通过之日起至第五届董事会届满之日止。简历详见附件。 二、选举公司第五届董事会各专门委员会委员 公司监事会选举赵玲女士为第五届监事会主席，任期三年，自本次会议通过 之日起至第五届监事会届满之日止。简历详见 ...

Investment Rating - The report maintains an "Outperform" rating for the public utility and environmental protection sectors [6][9]. Core Views - The environmental sector's revenue in 2024 is projected to decline by 0.6% to CNY 364.236 billion, with net profit decreasing by 14.7% to CNY 23.058 billion. However, in Q1 2025, the sector is expected to see a revenue increase of 3.5% to CNY 81.243 billion and a net profit growth of 3.8% to CNY 8.232 billion [3][21]. - The report highlights the impact of the new market-oriented pricing reforms for renewable energy in Shandong, aiming for full market integration by the end of 2025 [2][16]. - The report emphasizes the importance of the carbon neutrality context, recommending investments in the new energy industry chain and comprehensive energy management [41][42]. Summary by Sections Market Review - The Shanghai Composite Index rose by 2.00%, while the public utility index increased by 2.22%, and the environmental index rose by 2.93% [1][43]. Important Policies and Events - Shandong's new pricing reform aims for full market integration of wind and solar energy by 2025, with differentiated policies for existing and new projects [2][16]. Financial Overview of the Environmental Sector - In 2024, only the solid waste management and water treatment sectors showed positive growth, while the environmental equipment sector saw a decline of over 30% [3][21]. - The atmospheric governance sector reported a loss increase, while the comprehensive environmental governance sector shifted from profit to loss [21][24]. Investment Strategy - Recommendations include major thermal power companies like Huadian International and regional electricity firms like Shanghai Electric, as well as leading renewable energy firms such as Longyuan Power and Three Gorges Energy [4][41]. - The report suggests focusing on "utility-like investment opportunities" within the environmental sector, recommending companies like China Everbright Environment and Zhongshan Public Utilities [42][41]. Key Company Profit Forecasts and Investment Ratings - Several companies, including Huadian International and Longyuan Power, are rated as "Outperform" with projected earnings per share (EPS) growth for 2025 [9][41].

Core Insights - The company reported a revenue of 3.61 billion yuan for 2024, representing a year-on-year increase of 13.6%, and a net profit attributable to shareholders of 210 million yuan, up 164.1% year-on-year [1] - In Q1 2025, the company achieved a revenue of 550 million yuan, a year-on-year increase of 1.4%, but reported a net loss of 21 million yuan, a reduction in loss of 4 million yuan year-on-year [1] - The company is a leader in high-end analytical instruments in China, established in 2002 and listed in 2011, with a strong focus on multiple technology platforms and applications across various sectors [1] Financial Performance - The gross profit margins for the company's core instrument, operational services, and environmental governance businesses in 2024 were 48.5%, 38.0%, and 27.3%, respectively, showing increases of 2.8 percentage points, 6.7 percentage points, and 4.6 percentage points year-on-year [2] - The subsidiary, Puyutech, generated a revenue of 1.45 billion yuan, a year-on-year growth of 20.6%, and achieved a net profit of 130 million yuan, marking a turnaround from losses [2] - The company has focused on its core instrument business while reducing investments in non-profitable segments, leading to significant improvements in profitability [2] Cost Management - In Q1 2025, the company's net profit margin reached 43.5%, with a year-on-year reduction in loss of 4.1 percentage points [2] - The company successfully reduced its expense ratios across various categories, including sales, management, financial, and R&D expenses, contributing to overall profitability enhancement [2] Profit Forecast and Investment Recommendation - The company is expected to benefit from domestic substitution and equipment renewal policies, with projected net profits for 2025, 2026, and 2027 at 330 million yuan, 410 million yuan, and 490 million yuan, respectively [3] - Corresponding EPS estimates are 0.74 yuan, 0.92 yuan, and 1.08 yuan for the same years [3] - A target price of 25.90 yuan is set based on a 35 times PE ratio for 2025, with an initial "buy" rating [3]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of 25.90 CNY for the next six months, based on a current price of 20.95 CNY [1]. Core Insights - The company has turned profitable, with significant growth potential driven by domestic substitution and equipment upgrade policies. The report forecasts substantial increases in revenue and net profit over the next few years [6][24]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 3.61359 billion CNY, a year-on-year increase of 13.6%. The net profit attributable to the parent company was 206.86 million CNY, up 164.1% from the previous year. For Q1 2025, revenue was 550 million CNY, a 1.4% increase year-on-year, while the net profit was a loss of 21 million CNY, showing a reduction in losses compared to the previous year [6][14]. Business Model and Strategy - The company is a leader in high-end analytical instruments in China, focusing on core instrument business while reducing non-profitable segments. It has developed a "4+X" multi-business model covering various sectors including smart industry, smart environment, smart laboratory, and life sciences [7][12]. Profitability and Efficiency - The gross margins for the company's core instrument, operation services, and environmental governance businesses were 48.5%, 38.0%, and 27.3% respectively in 2024, showing improvements year-on-year. The company has implemented cost reduction and efficiency enhancement measures, leading to a significant decrease in expense ratios [6][17][19]. Earnings Forecast - The report projects net profits for 2025, 2026, and 2027 to be 332.24 million CNY, 413.02 million CNY, and 485.35 million CNY respectively, with corresponding EPS of 0.74 CNY, 0.92 CNY, and 1.08 CNY [24][26]. Valuation - The company is valued at a PE ratio of 35 times for 2025, which is lower than the average PE of comparable companies at 40.5 times. This reflects the company's potential to benefit from domestic substitution and equipment upgrade policies [24][27].

Core Viewpoint - The company reported a total operating revenue of 547 million yuan for Q1 2025, reflecting a year-on-year growth of 1.38%, while the net profit attributable to shareholders was -21 million yuan, showing a year-on-year increase of 18.77%. Despite the negative profit, this indicates significant progress in cost control and efficiency improvement [1]. Group 1: Financial Performance - The company achieved total operating revenue of 547 million yuan in Q1 2025, with a year-on-year growth of 1.38% [1]. - The net profit attributable to shareholders was -21 million yuan, representing a year-on-year increase of 18.77% [1]. - The revenue structure shows seasonal characteristics, with Q1 typically accounting for about 15% of total annual revenue, leading to potential fluctuations in overall gross margin due to individual contract differences [1]. Group 2: Business Segments and Growth Opportunities - The company operates in various sectors including environmental monitoring, emergency safety, semiconductors, materials, food and drug, and life sciences, with a strong focus on innovative product offerings and solutions [1]. - Traditional environmental and industrial business segments are expected to maintain stable growth, while the laboratory instruments sector is anticipated to accelerate, particularly in emerging areas like carbon monitoring and medical equipment [2]. - The company has established multiple business units focused on different application scenarios in clinical research and early disease diagnosis, which have launched new products and obtained medical device registrations [3]. Group 3: Technological Advancements - The company has optimized its business units and strengthened cost control, leading to significant improvements in human efficiency [3]. - In the field of mass spectrometry, the company has mastered several key technologies and successfully industrialized various high-end mass spectrometers, enhancing its competitiveness in high-level scientific research [3]. - The company is accelerating the research and promotion of advanced mass spectrometry technologies, which will enrich its product line and support future growth in the life sciences instrument market [3][4].

Group 1 - The Terahertz concept sector increased by 2.90%, ranking fifth among concept sectors, with 22 stocks rising, including Sifang Electronics which hit the daily limit, and others like Leike Defense and Yaguang Technology showing significant gains of 7.69% and 7.46% respectively [1] - The top gainers in the Terahertz concept sector included Sifang Electronics, ZTE Corporation, and Yaguang Technology, with net inflows of 9953.89 million, 7174.28 million, and 4470.21 million respectively [2][3] - The overall market saw a net inflow of 2.02 billion into the Terahertz concept sector, with 13 stocks receiving net inflows, and 6 stocks exceeding 3000 million in net inflows [1] Group 2 - The leading stocks by net inflow ratio included Sifang Electronics at 17.39%, Tongfang Co. at 10.47%, and Yaguang Technology at 9.35% [2] - The trading volume and turnover rates for the top stocks in the Terahertz concept sector were notable, with Sifang Electronics showing a turnover rate of 7.20% and ZTE Corporation at 1.79% [2][3] - The stocks with the largest declines included Juguang Technology and Shuo Beid, with declines of 0.80% and 0.07% respectively [1]

2025年05月07日，聚光科技2024年度网上业绩说明会在全景网顺利举行。出席本次业绩说明会的人员有 董事长顾海涛、总经理韩双来、财务负责人虞辉、董秘田昆仑、独立董事刘菁。 根据全景数据后台统计，在今天的交流过程中，来自全国多个省、市地区的投资者共向上市公司提问95 个，公司嘉宾共回答问题95个，答复率100.00%，充分实现了上市公司与投资者的良好互动。 2、问：领导，您好！我来自四川大决策公司在高端科学仪器国产化领域持续发力，针对当前国产仪器 在高端市场渗透率较低的现状，公司如何通过技术突破或合作模式提升市场竞争力？【征集问题】 回答：感谢您的关注！公司在现有技术路线的基础上，通过面向高端、自主可控方向开发产品，同时， 提升公司产品的各项性能，提升客户的满意度。通过差异化、智能化、自动化解决客户的痛点。谢谢！ 3、问：聚光科技在财务方面，如何进一步优化资产负债结构，降低资产负债率（目前为 63.64） ？例 如，在偿还债务、优化应收账款管理（应收账款达 8.38 亿元）等方面有哪些具体举措，以增强投资者 对公司财务健康状况的信心，稳定和推动股价上行？【征集问题】 回答：感谢您的关注！公司将持续优化资产负 ...